Literature DB >> 19391008

Spectrum of purpura fulminans.

A V Lalitha1, D Aruna, Anand Prakash, H M Nanjunda Swamy, S D Subba Rao.   

Abstract

Purpura Fulminans is a severe disorder of acute onset with high morbidity and mortality. It is characterized by DIC with thrombocytopenia, hyofibrinogenemia, hypothrombinemia and anemia. It most often occurs in young with sudden appearance of symmetrical, tender, ecchymotic skin lesions usually involving the lower extremities. An infectious and noninfectious etiology has been proposed. Early recognition and early therapy with appropriate antibiotics and heparin is known to limit both morbidity and mortality. This article reports 5 cases of Purpura Fulminans treated at our centre with review of etiology, pathogenesis, clinical features and treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19391008     DOI: 10.1007/s12098-009-0034-0

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  12 in total

1.  Purpura fulminans.

Authors:  J R Urbaniak; M T O'Neil; L C Meyer
Journal:  J Bone Joint Surg Am       Date:  1973-01       Impact factor: 5.284

2.  Purpura fulminans.

Authors:  D L Dudgeon; D R Kellogg; G S Gilchrist; M M Woolley
Journal:  Arch Surg       Date:  1971-09

3.  Outcome in children with purpura fulminans: report on 16 patients.

Authors:  Aytemiz Gürgey; Selin Aytac; Guler Kanra; Gulten Secmeer; Mehmet Ceyhan; Cigdem Altay
Journal:  Am J Hematol       Date:  2005-09       Impact factor: 10.047

4.  Purpura fulminans due to Staphylococcus aureus.

Authors:  Gary R Kravitz; David J Dries; Marnie L Peterson; Patrick M Schlievert
Journal:  Clin Infect Dis       Date:  2005-03-02       Impact factor: 9.079

5.  Protein C substitution in sepsis-associated purpura fulminans.

Authors:  E Rintala; M Kauppila; O P Seppälä; L M Voipio-Pulkki; V Pettilä; V Rasi; P Kotilainen
Journal:  Crit Care Med       Date:  2000-07       Impact factor: 7.598

6.  Use of protein-C concentrate, heparin, and haemodiafiltration in meningococcus-induced purpura fulminans.

Authors:  O P Smith; B White; D Vaughan; M Rafferty; L Claffey; B Lyons; W Casey
Journal:  Lancet       Date:  1997-11-29       Impact factor: 79.321

7.  Massive skin necrosis in Rocky Mountain spotted fever.

Authors:  G L Griffith; E A Luce
Journal:  South Med J       Date:  1978-11       Impact factor: 0.954

8.  The role of heparin in the prevention of extremity and digit necrosis in meningococcal purpura fulminans.

Authors:  N Kuppermann; S H Inkelis; R Saladino
Journal:  Pediatr Infect Dis J       Date:  1994-10       Impact factor: 2.129

Review 9.  Acute infectious purpura fulminans: pathogenesis and medical management.

Authors:  G L Darmstadt
Journal:  Pediatr Dermatol       Date:  1998 May-Jun       Impact factor: 1.588

Review 10.  Postinfectious purpura fulminans caused by an autoantibody directed against protein S.

Authors:  M Levin; B S Eley; J Louis; H Cohen; L Young; R S Heyderman
Journal:  J Pediatr       Date:  1995-09       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.